AXS logo

AXS

Axis Capital Holdings Limited

$103.86
+$0.68(+0.66%)
74
Overall
95
Value
70
Tech
57
Quality
Market Cap
$7.90B
Volume
831.61K
52W Range
$84.81 - $110.34
Target Price
$121.91

Latest News for AXS

Axis Capital Delivers Record Results, Stays Disciplined
TipRanks Auto-Generated Newsdesk3 days agoFeb 01, 2026

Axis Capital Holdings (($AXS)) has held its Q4 earnings call. Read on for the main highlights of the call. Axis Capital Earnings Call Highlights Re......

Axis Capital Grants Special Equity Award to CEO
TipRanks Auto-Generated Newsdesk4 days agoJan 30, 2026

Axis Capital ( ($AXS) ) just unveiled an update. On January 27, 2026, AXIS Capital’s board-level Human Capital and Compensation Committee granted a......

Wells Fargo Sticks to Their Buy Rating for Axis Capital (AXS)
TipRanks Auto-Generated Intelligence Newsdesk4 days agoJan 30, 2026

Wells Fargo analyst Elyse Greenspan maintained a Buy rating on Axis Capital today and set a price target of $121.00. According to TipRanks, Greensp......

NAXS Narrows 2025 Loss as New Owners and Board Pivot Strategy Toward Shareholder Value
TipRanks Sweden Auto-Generated Newsdesk5 days agoJan 29, 2026

NAXS AB ( ($SE:NAXS) ) has provided an announcement. NAXS AB reported a reduced full-year loss for 2025, with net profit improving to a negative MS......

Analysts Conflicted on These Healthcare Names: Hinge Health, Inc. Class A (HNGE), Axsome Therapeutics (AXSM) and TG Therapeutics (TGTX)
Howard Kim12 days agoJan 22, 2026

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hinge Health, Inc. Class A (HNGE – Research Report), Axsome Thera......

NAXS Steps Up Share Buybacks to Bolster Capital Structure and Shareholder Value
TipRanks Sweden Auto-Generated Newsdesk15 days agoJan 19, 2026

NAXS AB ( ($SE:NAXS) ) has shared an update. NAXS AB has repurchased 5,827 of its own shares on Nasdaq Stockholm between 12 and 16 January 2026 as ......

RBC Capital Reaffirms Their Buy Rating on Axis Capital (AXS)
TipRanks Auto-Generated Intelligence Newsdesk18 days agoJan 17, 2026

In a report released yesterday, Rowland Mayor from RBC Capital maintained a Buy rating on Axis Capital, with a price target of $125.00. According t......

Mizuho Securities Keeps Their Buy Rating on Axsome Therapeutics (AXSM)
TipRanks Auto-Generated Intelligence Newsdesk19 days agoJan 15, 2026

In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Axsome Therapeutics, with a price target of $217.00......

Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Vertex Pharmaceuticals (VRTX) and CareDx (CDNA)
Catie Powers21 days agoJan 13, 2026

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Axsome Therapeutics (AXSM – Research Report), Vert......

Axsome Therapeutics Reports Strong Preliminary 2025 Revenue Growth
TipRanks Auto-Generated Newsdesk22 days agoJan 12, 2026

Axsome Therapeutics ( ($AXSM) ) has provided an announcement. On January 12, 2026, Axsome Therapeutics reported preliminary, unaudited net product ......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 13 articles.

ABCD
1SymbolPriceChangeVol
2AXS$103.86+0.7%831.61K
3
4
5
6

Get Axis Capital Holdings Limited Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.